These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1808759)
1. Fibrinolytic activity in patients with idiopathic and secondary deep venous thrombosis. Harbourne T; O'Brien D; Nicolaides AN Thromb Res; 1991 Dec; 64(5):543-50. PubMed ID: 1808759 [TBL] [Abstract][Full Text] [Related]
2. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis. Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860 [TBL] [Abstract][Full Text] [Related]
3. Thrombosis after hip replacement. Relationship to the fibrinolytic system. Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386 [TBL] [Abstract][Full Text] [Related]
4. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism. Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786 [TBL] [Abstract][Full Text] [Related]
5. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
6. Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis. Stegnar M; Peternel P; Keber D; Vene N Thromb Res; 1991 Nov; 64(4):445-53. PubMed ID: 1788830 [TBL] [Abstract][Full Text] [Related]
7. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. van Giezen JJ; Boon GI; Jansen JW; Bouma BN Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851 [TBL] [Abstract][Full Text] [Related]
8. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051 [TBL] [Abstract][Full Text] [Related]
9. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion. Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322 [TBL] [Abstract][Full Text] [Related]
11. Altered fibrinolysis in DVT: influence of site of sampling. Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091 [TBL] [Abstract][Full Text] [Related]
12. Plasma fibrinolysis and postoperative deep vein thrombosis. Macintyre IM; Webber RG; Crispin JR; Jones DR; Wood JK; Allan NC; Prescott RJ; Ruckley CV Br J Surg; 1976 Sep; 63(9):694-7. PubMed ID: 963414 [TBL] [Abstract][Full Text] [Related]
13. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis. Páramo JA; Alfaro MJ; Rocha E Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269 [TBL] [Abstract][Full Text] [Related]
14. Indicators of depressed fibrinolytic activity in pre-operative prediction of deep venous thrombosis. Sue-Ling HM; Johnston D; Verheijen JH; Kluft C; Philips PR; Davies JA Br J Surg; 1987 Apr; 74(4):275-8. PubMed ID: 3107652 [TBL] [Abstract][Full Text] [Related]
15. Significance of idiopathic deep venous thrombosis. O'Connor NT; Cederholm-Williams SA; Fletcher EW; Allington M; Sharp AA Postgrad Med J; 1984 Apr; 60(702):275-7. PubMed ID: 6539470 [TBL] [Abstract][Full Text] [Related]
16. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059 [TBL] [Abstract][Full Text] [Related]
17. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Nilsson IM; Ljungnér H; Tengborn L Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic activity in plasma after gynecological and urological surgery. Aranda A; Páramo JA; Rocha E Haemostasis; 1988; 18(2):129-34. PubMed ID: 3137141 [TBL] [Abstract][Full Text] [Related]
20. Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery. Mellbring G; Dahlgren S; Wiman B; Sunnegårdh O Thromb Res; 1985 Jul; 39(2):157-63. PubMed ID: 2411000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]